Buy BSX by Dec 11, 2026.

Medical Device Maker **Boston Scientific** (NYSE: BSX) trades at **$42.98** ($62.3B market cap), down over **58%** from its 52-week high of $105.65. The sell-off has driven BSX’s standard valuation multiples to multi-year lows, conflicting sharply with its underlying operational performance. [https://i.imgur.com/L6hmxjB.png](https://i.imgur.com/L6hmxjB.png) The recent insider activity in Boston Scientific (BSX) reveals an aggressive **cluster of open-market purchases** between May and August 2026, marking a complete reversal from the routine executive selling observed in 2025 and early 2026. [http://openinsider.com/search?q=bsx](http://openinsider.com/search?q=bsx) * **High-Conviction CEO …